Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Ocular therapy using glucocorticoid derivatives selectively penetrating posterior segment tissues

Ocular therapy using glucocorticoid derivatives selectively penetrating posterior segment tissues

US Patent 9259429 · Granted Feb 16, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Biodegradable intravitreal tyrosine kinase implants2021
4-pregenen-11β-17-21-triol-3,20-dione derivatives2019
Ocular therapy using glucocorticoid derivatives selectively penetrating posterio2019
Ocular therapy using glucocorticoid derivatives selectively penetrating posterio2019
Pharmaceutical compositions and methods of use of 4-pregenen-11β-17-21-triol-3,22019
Biodegradable intravitreal tyrosine kinase implants2018
Ocular therapy using glucocorticoid derivatives selectively penetrating posterio2017
Ocular therapy using glucocorticoid derivatives selectively penetrating posterio2017
Pharmaceutical compositions and methods of use of 4-pregenen-11β-17-21-triol-3,22017
4-pregenen-11β-17-21-triol-3,20-dione derivatives2016
Biodegradable intravitreal tyrosine kinase implants2016
Sustained release intraocular implants containing tyrosine kinase inhibitors and2015